User profiles for K. Theodoropoulos
Konstantinos C.TheodoropoulosInterventional Cardiology Fellow, Liverpool Heart and Chest Hospital Verified email at nhs.net Cited by 1094 |
Prognostic role of inflammatory cytokines and novel adipokines in acute myocardial infarction: An updated and comprehensive review
…, V Lambadiari, S Alexiou, KC Theodoropoulos… - Cytokine, 2022 - Elsevier
Acute myocardial infarction (AMI) is one of the major causes of morbidity and mortality
worldwide. The inflammation response during and after AMI is common and seems to play a key …
worldwide. The inflammation response during and after AMI is common and seems to play a key …
Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment–elevation myocardial infarction
…, G Kassimis, KC Theodoropoulos… - Circulation …, 2012 - Am Heart Assoc
Background— Ticagrelor and prasugrel provide stronger platelet inhibition compared with
clopidogrel. Direct pharmacodynamic comparison between them has not yet been reported in …
clopidogrel. Direct pharmacodynamic comparison between them has not yet been reported in …
Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical …
…, K Sudhir, RS Smith, S Cao, K Theodoropoulos… - JACC: Cardiovascular …, 2013 - jacc.org
Objectives : This study sought to investigate whether the everolimus-eluting stent (EES) is
superior to the paclitaxel-eluting stent (PES) with respect to long-term individual clinical …
superior to the paclitaxel-eluting stent (PES) with respect to long-term individual clinical …
Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a …
…, G Kassimis, KC Theodoropoulos… - Journal of the American …, 2012 - jacc.org
Objectives : The study aimed to compare the antiplatelet action of ticagrelor with prasugrel
in acute coronary syndrome (ACS) patients with high on-treatment platelet reactivity (HTPR) …
in acute coronary syndrome (ACS) patients with high on-treatment platelet reactivity (HTPR) …
Intracoronary thrombolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: an updated meta-analysis …
S Alexiou, D Patoulias, KC Theodoropoulos… - … Drugs and Therapy, 2024 - Springer
Background Primary percutaneous coronary intervention (PPCI) is the standard reperfusion
treatment in ST-segment elevation myocardial infarction (STEMI). Intracoronary thrombolysis …
treatment in ST-segment elevation myocardial infarction (STEMI). Intracoronary thrombolysis …
[HTML][HTML] Molecular epidemiology and antifungal susceptibility of Trichophyton isolates in Greece: emergence of terbinafine-resistant Trichophyton mentagrophytes …
M Siopi, I Efstathiou, K Theodoropoulos, S Pournaras… - Journal of Fungi, 2021 - mdpi.com
Trichophyton isolates with reduced susceptibility to antifungals are now increasingly reported
worldwide. We therefore studied the molecular epidemiology and the in vitro antifungal …
worldwide. We therefore studied the molecular epidemiology and the in vitro antifungal …
Real‐world data on the efficacy and safety of apremilast in patients with moderate‐to‐severe plaque psoriasis
…, N Rompoti, K Theodoropoulos… - Journal of the …, 2018 - Wiley Online Library
Background Psoriasis is a chronic inflammatory skin disease, which requires long‐term, safe
and effective treatment. Apremilast, a small‐molecule PDE 4 inhibitor, has been introduced …
and effective treatment. Apremilast, a small‐molecule PDE 4 inhibitor, has been introduced …
Agent Based Modelling and Simulation tools: A review of the state-of-art software
S Abar, GK Theodoropoulos, P Lemarinier… - Computer Science …, 2017 - Elsevier
The key intent of this work is to present a comprehensive comparative literature survey of the
state-of-art in software agent-based computing technology and its incorporation within the …
state-of-art in software agent-based computing technology and its incorporation within the …
Lowering interleukin-12 activity improves myocardial and vascular function compared with tumor necrosis factor-a antagonism or cyclosporine in psoriasis
…, K Gravanis, K Theodoropoulos… - Circulation …, 2017 - Am Heart Assoc
Background— Interleukin (IL)-12 activity is involved in the pathogenesis of psoriasis and
acute coronary syndromes. We investigated the effects of IL-12 inhibition on vascular and left …
acute coronary syndromes. We investigated the effects of IL-12 inhibition on vascular and left …
Overview of mitral regurgitation in Europe: results from the European Registry of mitral regurgitation (EuMiClip)
…, M Monaghan, KC Theodoropoulos… - European Heart …, 2018 - academic.oup.com
Aims To determine the prevalence of mitral regurgitation (MR) in a large cohort of consecutive
patients undergoing clinically indicated echocardiography and to examine the distribution …
patients undergoing clinically indicated echocardiography and to examine the distribution …